E
MIRA Pharmaceuticals, Inc. MIRA
$1.41 -$0.01-0.70% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Total Cash And Short-Term Investments -39.44% -57.42% -31.65% 46.77% -19.98%
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -35.44% 189.95% -36.84% -20.26% -41.39%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -38.98% -52.73% -31.75% 44.29% -21.04%

Total Current Assets -38.98% -52.73% -31.75% 44.29% -21.04%
Net Property, Plant & Equipment -- -- -- -- --
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 0.00% 0.00% 0.00% -57.45% -11.02%
Total Assets -37.99% -52.10% -31.49% 41.48% -20.83%

Total Accounts Payable 196.43% -86.08% 4.40% -11.42% 22.91%
Total Accrued Expenses -- -- -- -- 0.00%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities 181.07% -85.32% 4.40% -13.03% 22.18%

Total Current Liabilities 181.07% -85.32% 4.40% -13.03% 22.18%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 181.07% -85.32% 4.40% -13.03% 22.18%

Common Stock & APIC 2.52% 2.80% 3.38% 12.63% 2.88%
Retained Earnings -4.97% -6.12% -8.97% -8.28% -7.35%
Treasury Stock & Other -- -- -- -- --
Total Common Equity -55.97% -41.17% -38.44% 61.05% -29.71%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity -55.97% -41.17% -38.44% 61.05% -29.71%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity -55.97% -41.17% -38.44% 61.05% -29.71%